Last reviewed · How we verify

NCT04813289

Review of Anaesthetic Practice in Orthognathic Surgery

Completed Last updated 24 March 2021
What this trial tests

trial in Maxillofacial Abnormalities in 269 participants. Completed in 31 December 2019.

Timeline
1 July 2017
Primary endpoint
31 December 2019
31 December 2019

Quick facts

Lead sponsorSingapore General Hospital
StatusCompleted
Study typeOBSERVATIONAL
Enrollment269
Start date1 July 2017
Primary completion31 December 2019
Estimated completion31 December 2019
Sites1 location across Singapore

Conditions studied

Sponsor

Singapore General Hospital

Who can join

Eligibility, any sex, with Maxillofacial Abnormalities or Blood Pressure. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Orthognathic surgeries for maxillofacial deformities are commonly performed globally. However, they are associated with significant blood loss which can affect the surgical field and result in blood transfusion and its risks. We aim to review the different hypotensive anaesthetic practices for orthognathic surgeries, and their effects on intraoperative blood loss and transfusion requirements.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

  1. Is hypotensive anaesthesia guided by invasive intraarterial monitoring required for orthognathic surgery? - A retrospective review of anaesthetic practice and intraoperative blood loss in orthognathic surgery in a tertiary hospital.
    Lee YL, Thangavelautham S, Harikrishnan S, Karthekeyan R, et al · · 2021 · cited 7× · PMID 34321683 · DOI 10.4103/ija.ija_201_21

Verify or expand the search:

Other Singapore General Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04813289.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing